Диссертация (1154752), страница 22
Текст из файла (страница 22)
Особенности фармакотерапии в современной педиатрическойпрактике: взаимосвязь педиатрии и фармации / Т.Д. Синева // Здоровье –основа человеческого потенциала: проблемы и пути их решения. – 2012. –Т. 7, № 2. – С. 706–70751.Специалист по фармакологической безопасности в фармацевтическойкомпании [Текст] / Ю.Б. Белоусов, А.С. Колбин, А.Т. Бурбулло, К.А.130Загородникова // Качественная клиническая практика. – 2010. – №1. – С.81–8652.Структура «off-label» назначений лекарственных препаратов у детей:анализ российской базы данных спонтанных сообщений [Текст] / А.Р.Титова, И.Л. Асецкая, В.А.
Поливанов, С.К. Зырянов, С.В. Глаголев //Педиатрия. – 2016. – Т.95, № 6. – С. 75–8453.Таточенко, В.К. Побочные действия лекарств в педиатрической практике[Текст] / В.К. Таточенко // Здоровье Украины. – 2007. – №5/1. – С. 64–6654.Таточенко, В.К. Рациональная терапия ОРЗ [Текст] / В.К. Таточенко //Лечащий врач. – 2011. – № 8.
– С. 52–5655.Тополянская,С.В. Общиеметодологические проблемыпроведенияклинических исследований у детей [Текст] / С.В. Тополянская //Педиатрическая фармакология. – 2010. – Т.7, № 5. – С. 6–1056.Федеральные клинические рекомендации по оказанию медицинскойпомощи детям с артериальной гипертензией (проект) // Союз педиатровРоссии; Ассоциация детских кардиологов России. – 2015.
– Режим доступа:http://www.cardio-rus.ru/doc/arter_hyper.pdf. – (дата обращения: 22.05.2017)57.Циммерман, Я.С. Нерешенные и спорные проблемы современнойгастроэнтерологии [Текст] / Я.С. Циммерман. – М.: МЕДпресс-информ,2013. – 224 с.58.Якимова, Ю.Н. Современные проблемы функционирования формулярнойсистемы в педиатрической практике [Электронный ресурс] / Ю.Н.
Якимова// Бюллетень медицинских Интернет-конференций. – 2013. – Т.3, № 12 . –Режимдоступа:http://medconfer.com//files/archive/Bulletin-of-MIC-2013-12.pdf . – (дата обращения: 16.07.2016)59.A method for estimating the probability of adverse drug reactions [Text] / C.A.Naranjo, U.
Busto, E.M. Sellers E.M. [et al.] // Pharmacol Ther. – 1981. – Vol.30. – P. 239–24513160. A prospective study of adverse drug reactions in hospitalized children [Text] / I.Martínez-Mir, M. García-López, V. Palop, J.M. Ferrer, E. Rubio, F.J. MoralesOlivas // Br J Clin Pharmacol. – 1999. – Vol. 47, № 6. – P.
681–688.61.A questionnaire-based study in Calabria on the knowledge of off-label drugs inpediatrics [Text] / F. Saullo, E. Saullo, M. Caloiero, M. Menniti [et al.] // JPharmacol Pharmacother. – 2013. – Vol. 4, Suppl. 1. – P. 51–54.62. A retrospective review of paediatric adverse drug reactions reported inLombardy and Croatia from 2005 to 2013 [Text] / C. Carnovale, M. Gentili, M.Matacena [et al.] // Expert Opin Drug Saf. – 2016. – Vol.
15, Suppl. 2. – P. 35–4363. A study of adverse drug reactions in pediatric patients [Text] / R. Priyadharsini,A. Surendiran, C. Adithan, S. Sreenivasan, F.K. Sahoo // J PharmacolPharmacother. – 2011. – Vol. 2, № 4. – P. 277–28064.A survey of spontaneous reporting of adverse drug reactions in 10 years ofactivity in a pharmacovigilance centre in Portugal [Text] / J. Marques, I. RibeiroVaz, A.C.
Pereira, J. Polónia // Int J Pharm Pract. – 2014. – Vol. 22, № 4. – P.275–28265.Aagaard, L. Adverse drug reactions in the paediatric population in Denmark: aretrospective analysis of reports made to the Danish Medicines Agency from1998 to 2007 [Text] / L. Aagaard, C.B. Weber, E.H. Hansen // Drug Saf.
– 2010.– Vol. 33, № 4. – P. 327–33966.Aagaard, L. Information about adverse drug reactions reported in children: aqualitative review of empirical studies [Text] / L. Aagaard, A. Christensen, E.H.Hansen // Br J Clin Pharmacol. – 2010. – Vol. 70, № 4. – P. 481–49167.Aagaard, L. Knowledge creation about adverse drug reactions in the paediatricpopulation [Text] / L. Aagaard // Ugeskr Laeger. – 2013. – Vol. 175, № 6. – P.342–34568. Aagaard, L. Adverse drug reactions in children reported by European consumersfrom 2007 to 2011[Text] / L. Aagaard, E.H. Hansen // Int J Clin Pharm. – 2014.– Vol. 36, № 2. – P.
295–30213269. Adverse drug events and medication errors in Japanese paediatric inpatients: aretrospective cohort study [Text] / M. Sakuma, H. Ida, T. Nakamura [et al.] //BMJ Qual Saf. – 2014. – Vol. 23, № 10. – P. 830–83770. Adverse drug events in hospitalized children at Ethiopian University Hospital: aprospective observational study [Electronic resource] / T.C.
Eshetie, B.Hailemeskel, N. Mekonnen [et al.] // BMC Pediatr. – 2015. – Vol. 15. – URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4502527/pdf/12887_2015_Article_401.pdf. – (accessed: 17.12.2016)71. Adverse drug reaction active surveillance: developing a national network inCanada's children's hospitals [Text] / B. Carleton, R. Poole, M. Smith, J. Leeder[et al.] // Pharmacoepidemiol Drug Saf. – 2009. – Vol. 18, № 8. – P. 713–72172. Adverse drug reactions and off-label and unlicensed medicines in children: aprospective cohort study of unplanned admissions to a paediatric hospital [Text]/ J.R. Bellis, J.J.
Kirkham, A.J. Nunn, M. Pirmohamed // Br J Clin Pharmacol. –2014. – Vol. 77, № 3. – P. 545–553.73. Adverse drug reactions causing admission to a paediatric hospital [Electronicresource] / R.M. Gallagher, J.R. Mason, K.A. Bird [et al.] // PLoS One. – 2012. –Vol.7,№12.–URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514275/pdf/pone.0050127.pdf.– (accessed:12.12.2016)74.
Adverse drug reactions causing admission to a paediatric hospital: a pilot study[Text] / R.M. Gallagher, K.A. Bird, J.R. Mason [et al.] // J Clin Pharm Ther. –2011. – Vol. 36, № 2. – P. 194–19975.Adverse drug reactions in a paediatric intensive care unit [Text] / H.
Telechea, N.Speranza, L. Lucas, G. Giachetto, L. Nanni, A. Menchaca // Farm Hosp. – 2012.– Vol. 36, № 5. – P. 403–40976. Adverse drug reactions in children reported by means of the yellow card inSpain [Text] / F.J. Morales-Olivas, I. Martínez-Mir, J.M.
Ferrer, E. Rubio, V.Palop // J Clin Epidemiol. – 2000. – Vol. 53, № 10. – P. 1076–108013377. Adverse drug reactions in children: 10 years of pharmacovigilance [Text] / S.Damien, H. Patural, B. Trombert-Paviot, M.N. Beyens // Arch Pediatr. – 2016. –Vol. 23, № 5. – P. 468–47678.Adverse drug reactions in children: a ten-year review of reporting to thePortuguese Pharmacovigilance System [Text] / L.
Nogueira Guerra, M.T.Herdeiro, I. Ribeiro-Vaz [et al.] // Expert Opin Drug Saf. –2015. – Vol. 14, №12.– P. 1805–181379. Adverse drug reactions in children--a systematic review [Electronic resource] /R.M. Smyth, E. Gargon, J. Kirkham, L. Cresswell [et al.] // PLoS One. – 2012. –Vol.№7,–3.URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293884/pdf/pone.0024061.pdf.– (accessed: 19.12.2016)80. Adverse Drug Reactions in Children--International Surveillance and Evaluation(ADVISE): a multicentre cohort study [Text] / A.N.
Rashed, I.C. Wong, N.Cranswick [et al.] // Drug Saf. – 2012. – Vol. 35, № 6. – P. 481–49481. Adverse drug reactions in hospitalised children in Germany are decreasing:results of a nine year cohort-based comparison [Electronic resource] / A.K.Oehme, A.N. Rashed, B. Hefele, I.C. Wong, W. Rascher, A. Neubert // PLoSOne.–2012.–Vol.7,№9.–URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445603/pdf/pone.0044349.pdf.– (accessed: 04.11.2016)82. Adverse drug reactions in hospitalized Colombian children [Text] / R. de LasSalas, D.
Díaz-Agudelo, F.J. Burgos-Flórez, C. Vaca, D.V. Serrano-Meriño //Colomb Med (Cali). – 2016. – Vol. 47, № 3. – P. 142–14783. Adverse Drug Reactions in Hospitalized Pediatric Patients: A ProspectiveObservational Study [Text] / J. Kurian, J. Mathew, K. Sowjanya [et al.] // IndianJ Pediatr. – 2016. – Vol. 83, № 5.
– P. 414–41984. Adversedrugreactionsinpediatrics:Experienceofaregionalpharmacovigilance center [Text] / C. Saint-Martin, L. Kanagaratnam, P. deBoissieu [et al.] // Therapie. – 2016. – Vol. 71, № 5. – P. 467–47313485.Adverse Drug Reactions of Spontaneous Reports in Shanghai PediatricPopulation [Electronic resource] / Hui Li, Xiao-Jing Guo, Xiao-Fei Ye [et al.] //PLoSOne.–2014.–Vol.9,№2.–URL:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933652/pdf/pone.0089829.pdf.– (accessed: 23.04.2016)86.